Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2025-12-25 @ 5:22 PM
NCT ID:
NCT03934203
Pre Assignment Details:
All subjects were screened for eligibility prior to participation in the trial. Subjects attended a specialist site which ensured that they (the subjects) strictly met all inclusion and none of the exclusion criteria. Subjects were not to be allocated to a treatment group if any of the entry criteria were violated. Abbreviation: mg=milligram.
There was a washout period of at least 6 days between treatments.
Recruitment Details:
This was a randomized, placebo-controlled, double-blind trial with crossover design with 5 treatment periods, 15 treatment sequences based on a balanced, Prescott triple Latin square design with a wash-out period of at least 6 days between treatments: 50 mg BI 409306, 250 mg BI 409306, 400 mg moxifloxacin (positive control, open-label), placebo (2 periods).
Study:
NCT03934203
Study Brief:
Results Section:
NCT03934203